Inspection Record

First Pharma Associates LLC — FDA 483 Findings

US FDAInspected 2019-06-07Published 2019-08-21 9 findingsTraining and personnelOther quality systemEquipment and facilityAseptic processing and sterility assuranceContamination control

Inspectors Jeffrey P. Raimondi · Linda F. MurphyThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Training and personnel

Personnel were observed manually contacting the inner surface of the container or closure.

2Other quality system

JSO-5 classified areas were not certified under dynamic conditions.

3Equipment and facility

The ISO-classified areas have difficult to clean, particle-generating, or visibly dirty equipment or surfaces.

4Aseptic processing and sterility assurance

Media fills were not performed that closely simulate aseptic production operations incorporating, as appropriate, worst-case activities and conditions that provide a challenge to aseptic operations.

5Aseptic processing and sterility assurance

Personnel were observed conducting aseptic manipulations or placing equipment/supplies in an area that blocked the movement of first pass air around an open unit, whether before or after it is filled with sterile product.

6Equipment and facility

The facility is designed and/or operated in a way that permits poor flow of personnel or materials.

7Contamination control

Non-microbial contamination was observed in your production area.

8Contamination control

Hazardous drugs were produced without providing adequate containment, segregation, and/or cleaning of work surfaces, utensils, and/or personnel to prevent cross-contamination.

9Equipment and facility

Inadequate pressure differentials between higher quality air rooms and lower quality air rooms were observed.

About this record

Extracted automatically from the document US FDA published on 2019-08-21. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

First Pharma Associates LLC company profile — full history US FDA documents, 2019 Go to Findings search